Start-Up Spotlight: GlucoModicum Plans To Disrupt Glucose Monitoring With Painless Wearable
Executive Summary
Medtech Insight spoke to the CEO of GlucoModicum to learn more about its approach to developing a pain-free, convenient glucose monitor for people managing their diabetes.
You may also be interested in...
Nemaura’s SugarBEAT Non-Invasive CGM Earns CE Mark
SugarBEAT is a non-invasive, needle-free, disposable adhesive skin-patch connected to a rechargeable transmitter. The company says it is the world’s first non-invasive continuous glucose monitor.
Paige Secures Eighth CE Mark For Cancer Identification AI
The Memorial Sloan Kettering spin-out has received CE-IVD and UKCA marks for its artificial intelligence software designed to identify HER2 expression in biopsies.
What Do Speedboats Have To Do with Surgery?
Nothing except a name, but Creo Medical says its Speedboat Inject device can turn some surgeries from prolonged hospital stays into one-day visits.